Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > Effect of Cholesteryl Esters on PS1 and on ABeta Ratios Updated On: Jan. 19, 2025
Alzheimer's Disease Research Grant

Effect of Cholesteryl Esters on PS1 and on ABeta Ratios

BFF logo

Principal Investigator

Dora Kovacs, PhD

Massachusetts General Hospital

Charlestown, MA, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$200,000

Active Dates

April 01, 2001 - March 31, 2003

Grant ID

A2001047

Summary

High cholesterol levels have long been associated with atherosclerosis. Recent studies show that high cholesterol levels are also linked to the increased appearance of the senile plaques and neurofibrillary tangles characteristic of Alzheimer’s disease. One possible explanation is that cholesterol inside the cellular membranes may somehow regulate the enzymes (secretases) that generate the amyloid beta peptide found in senile plaques. The cholesterol content in cellular membranes is maintained by the action of an enzyme called ACAT, which moves excess cholesterol from the membrane into the cell’s cytoplasm in the form of insoluble lipid droplets. In earlier work, Dr. Kovacs found that decreased lipid droplets led to a decrease in the production of amyloid beta, whereas abnormally high levels of lipid droplets (even with normal membrane cholesterol levels) led to an increase in amyloid beta production. Dr. Kovacs suggests that the mechanism for this may involve the stabilization of presenilins, Alzheimer-associated proteins responsible for the production of amyloid beta. Dr. Kovacs is now exploring the mechanism by which presenilin activity and the production of amyloid beta may be regulated by lipid droplets. Understanding this mechanism could provide the basis for developing ACAT inhibitors that would lower amyloid beta generation and slow or prevent AD-related neuropathology.